Table 2 CD10 staining scores in cases with positive expression according to the histologic grade and pathologic stage
From: CD10 expression in urothelial carcinoma of the bladder
| Â | CD10 | Total | |||
|---|---|---|---|---|---|
| Â | 1+ No. (%) | 2+ No. (%) | Â | ||
Grade | Â | Â | Â | Â | Â |
Low-grade | 35 | (97.2%) | 1 | (2.8%) | 36 (22.9%) |
High-grade | 30 | (24.8%) | 91* | (75.2%) | 121 (77.1%) |
pTa | 45 | (60.0%) | 30 | (40.0%) | 75 (47.8%) |
pT1 | 13 | (28.9%) | 32* | (71.1%) | 45 (28.7%) |
pT2-3 | 7 | (18.9%) | 30* | (81.1%) | 37 (23.5%) |